Idarucizumab, a Specific Reversal Agent for Dabigatran: Mode of Action, Pharmacokinetics and Pharmacodynamics, and Safety and Efficacy in Phase 1 Subjects
| Autor: | Reilly, Paul A., van Ryn, Joanne, Grottke, Oliver, Glund, Stephan, Stangier, Joachim |
|---|---|
| Zdroj: | In The American Journal of Medicine November 2016 129(11) Supplement:S64-S72 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|